Global Reritinib Mesylate Tablets Supply, Demand and Key Producers, 2026-2032
The global Reritinib Mesylate Tablets market size is expected to reach $ 122 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032).
Reritinib Mesylate Tablets are a highly selective oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with reritinib mesylate as the main ingredient. This drug can irreversibly inhibit EGFR sensitive mutations and T790M resistance mutations, block downstream signaling pathway transmission, inhibit tumor cell proliferation, invasion and metastasis, and exert antitumor effects. Clinically, it is mainly used for locally advanced or metastatic non-small cell lung cancer with EGFR T790M mutation-positive after progression on EGFR tyrosine kinase inhibitor therapy. Characterized by high targeting, convenient oral administration, controllable drug resistance and favorable safety profile, it is an important second-line targeted therapeutic drug for advanced non-small cell lung cancer.In 2025, global Reritinib Mesylate Tablet production reached approximately 120,000 units.
As a domestic third-generation EGFR-TKI, Reritinib Mesylate Tablets are an important innovative product in China's lung cancer targeted therapy market. Relying on its unique molecular structure and excellent clinical efficacy, it has a differentiated advantage in the domestic competitive landscape of third-generation EGFR-TKIs. The drug is approved for non-small cell lung cancer positive for EGFR-sensitive mutations and T790M resistance mutations, with outstanding clinical efficacy and safety. It has also been included in the national medical insurance catalogue, significantly improving patients’ medication accessibility. With the implementation of medical insurance coverage for first-line indications and the upgrading of clinical guideline recommendations, its market penetration continues to rise, forming unique competitiveness among similar domestic drugs. In the future, with the advancement of combination therapy research, indication expansion, and optimization of medical insurance policies, Reritinib Mesylate Tablets will further consolidate its market position, promote a higher level of import substitution of domestic EGFR-targeted drugs, and support the high-quality development of China's precision lung cancer therapy market.
This report studies the global Reritinib Mesylate Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Reritinib Mesylate Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Reritinib Mesylate Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Reritinib Mesylate Tablets total production and demand, 2021-2032, (Units)
Global Reritinib Mesylate Tablets total production value, 2021-2032, (USD Million)
Global Reritinib Mesylate Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Reritinib Mesylate Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Reritinib Mesylate Tablets domestic production, consumption, key domestic manufacturers and share
Global Reritinib Mesylate Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Reritinib Mesylate Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Reritinib Mesylate Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Reritinib Mesylate Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanjing Sanhome Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Reritinib Mesylate Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Reritinib Mesylate Tablets Market, By Region:
1. How big is the global Reritinib Mesylate Tablets market?
2. What is the demand of the global Reritinib Mesylate Tablets market?
3. What is the year over year growth of the global Reritinib Mesylate Tablets market?
4. What is the production and production value of the global Reritinib Mesylate Tablets market?
5. Who are the key producers in the global Reritinib Mesylate Tablets market?
6. What are the growth factors driving the market demand?
Reritinib Mesylate Tablets are a highly selective oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with reritinib mesylate as the main ingredient. This drug can irreversibly inhibit EGFR sensitive mutations and T790M resistance mutations, block downstream signaling pathway transmission, inhibit tumor cell proliferation, invasion and metastasis, and exert antitumor effects. Clinically, it is mainly used for locally advanced or metastatic non-small cell lung cancer with EGFR T790M mutation-positive after progression on EGFR tyrosine kinase inhibitor therapy. Characterized by high targeting, convenient oral administration, controllable drug resistance and favorable safety profile, it is an important second-line targeted therapeutic drug for advanced non-small cell lung cancer.In 2025, global Reritinib Mesylate Tablet production reached approximately 120,000 units.
As a domestic third-generation EGFR-TKI, Reritinib Mesylate Tablets are an important innovative product in China's lung cancer targeted therapy market. Relying on its unique molecular structure and excellent clinical efficacy, it has a differentiated advantage in the domestic competitive landscape of third-generation EGFR-TKIs. The drug is approved for non-small cell lung cancer positive for EGFR-sensitive mutations and T790M resistance mutations, with outstanding clinical efficacy and safety. It has also been included in the national medical insurance catalogue, significantly improving patients’ medication accessibility. With the implementation of medical insurance coverage for first-line indications and the upgrading of clinical guideline recommendations, its market penetration continues to rise, forming unique competitiveness among similar domestic drugs. In the future, with the advancement of combination therapy research, indication expansion, and optimization of medical insurance policies, Reritinib Mesylate Tablets will further consolidate its market position, promote a higher level of import substitution of domestic EGFR-targeted drugs, and support the high-quality development of China's precision lung cancer therapy market.
This report studies the global Reritinib Mesylate Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Reritinib Mesylate Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Reritinib Mesylate Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Reritinib Mesylate Tablets total production and demand, 2021-2032, (Units)
Global Reritinib Mesylate Tablets total production value, 2021-2032, (USD Million)
Global Reritinib Mesylate Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Reritinib Mesylate Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Reritinib Mesylate Tablets domestic production, consumption, key domestic manufacturers and share
Global Reritinib Mesylate Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Reritinib Mesylate Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Reritinib Mesylate Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Reritinib Mesylate Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanjing Sanhome Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Reritinib Mesylate Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Reritinib Mesylate Tablets Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 100mg / tablet
- 80mg / tablet
- Bottle
- Box
- Hospital
- Retail
- Online
- Innovator
- Generic
- EGFR-Sensitive Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer With T790M Resistance Mutation After Progression on EGFR-TKI Therapy
- Second-Line Targeted Therapy for Advanced Non-Small Cell Lung Cancer
- Others
- Nanjing Sanhome Pharmaceutical
1. How big is the global Reritinib Mesylate Tablets market?
2. What is the demand of the global Reritinib Mesylate Tablets market?
3. What is the year over year growth of the global Reritinib Mesylate Tablets market?
4. What is the production and production value of the global Reritinib Mesylate Tablets market?
5. Who are the key producers in the global Reritinib Mesylate Tablets market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Reritinib Mesylate Tablets Introduction
1.2 World Reritinib Mesylate Tablets Supply & Forecast
1.2.1 World Reritinib Mesylate Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Reritinib Mesylate Tablets Production (2021-2032)
1.2.3 World Reritinib Mesylate Tablets Pricing Trends (2021-2032)
1.3 World Reritinib Mesylate Tablets Production by Region (Based on Production Site)
1.3.1 World Reritinib Mesylate Tablets Production Value by Region (2021-2032)
1.3.2 World Reritinib Mesylate Tablets Production by Region (2021-2032)
1.3.3 World Reritinib Mesylate Tablets Average Price by Region (2021-2032)
1.3.4 North America Reritinib Mesylate Tablets Production (2021-2032)
1.3.5 Europe Reritinib Mesylate Tablets Production (2021-2032)
1.3.6 China Reritinib Mesylate Tablets Production (2021-2032)
1.3.7 Japan Reritinib Mesylate Tablets Production (2021-2032)
1.3.8 India Reritinib Mesylate Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Reritinib Mesylate Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Reritinib Mesylate Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Reritinib Mesylate Tablets Demand (2021-2032)
2.2 World Reritinib Mesylate Tablets Consumption by Region
2.2.1 World Reritinib Mesylate Tablets Consumption by Region (2021-2026)
2.2.2 World Reritinib Mesylate Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Reritinib Mesylate Tablets Consumption (2021-2032)
2.4 China Reritinib Mesylate Tablets Consumption (2021-2032)
2.5 Europe Reritinib Mesylate Tablets Consumption (2021-2032)
2.6 Japan Reritinib Mesylate Tablets Consumption (2021-2032)
2.7 South Korea Reritinib Mesylate Tablets Consumption (2021-2032)
2.8 ASEAN Reritinib Mesylate Tablets Consumption (2021-2032)
2.9 India Reritinib Mesylate Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Reritinib Mesylate Tablets Production Value by Manufacturer (2021-2026)
3.2 World Reritinib Mesylate Tablets Production by Manufacturer (2021-2026)
3.3 World Reritinib Mesylate Tablets Average Price by Manufacturer (2021-2026)
3.4 Reritinib Mesylate Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Reritinib Mesylate Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Reritinib Mesylate Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Reritinib Mesylate Tablets in 2025
3.6 Reritinib Mesylate Tablets Market: Overall Company Footprint Analysis
3.6.1 Reritinib Mesylate Tablets Market: Region Footprint
3.6.2 Reritinib Mesylate Tablets Market: Company Product Type Footprint
3.6.3 Reritinib Mesylate Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Reritinib Mesylate Tablets Production Value Comparison
4.1.1 United States VS China: Reritinib Mesylate Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Reritinib Mesylate Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Reritinib Mesylate Tablets Production Comparison
4.2.1 United States VS China: Reritinib Mesylate Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Reritinib Mesylate Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Reritinib Mesylate Tablets Consumption Comparison
4.3.1 United States VS China: Reritinib Mesylate Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Reritinib Mesylate Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Reritinib Mesylate Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
4.5 China Based Reritinib Mesylate Tablets Manufacturers and Market Share
4.5.1 China Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
4.6 Rest of World Based Reritinib Mesylate Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Reritinib Mesylate Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg / tablet
5.2.2 80mg / tablet
5.3 Market Segment by Type
5.3.1 World Reritinib Mesylate Tablets Production by Type (2021-2032)
5.3.2 World Reritinib Mesylate Tablets Production Value by Type (2021-2032)
5.3.3 World Reritinib Mesylate Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Reritinib Mesylate Tablets Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Bottle
6.2.2 Box
6.3 Market Segment by Packaging
6.3.1 World Reritinib Mesylate Tablets Production by Packaging (2021-2032)
6.3.2 World Reritinib Mesylate Tablets Production Value by Packaging (2021-2032)
6.3.3 World Reritinib Mesylate Tablets Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNEL
7.1 World Reritinib Mesylate Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channel
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channel
7.3.1 World Reritinib Mesylate Tablets Production by Sales Channel (2021-2032)
7.3.2 World Reritinib Mesylate Tablets Production Value by Sales Channel (2021-2032)
7.3.3 World Reritinib Mesylate Tablets Average Price by Sales Channel (2021-2032)
8 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
8.1 World Reritinib Mesylate Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Production Technology
8.2.1 Innovator
8.2.2 Generic
8.3 Market Segment by Production Technology
8.3.1 World Reritinib Mesylate Tablets Production by Production Technology (2021-2032)
8.3.2 World Reritinib Mesylate Tablets Production Value by Production Technology (2021-2032)
8.3.3 World Reritinib Mesylate Tablets Average Price by Production Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Reritinib Mesylate Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 EGFR-Sensitive Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
9.2.2 Non-Small Cell Lung Cancer With T790M Resistance Mutation After Progression on EGFR-TKI Therapy
9.2.3 Second-Line Targeted Therapy for Advanced Non-Small Cell Lung Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Reritinib Mesylate Tablets Production by Application (2021-2032)
9.3.2 World Reritinib Mesylate Tablets Production Value by Application (2021-2032)
9.3.3 World Reritinib Mesylate Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Nanjing Sanhome Pharmaceutical
10.1.1 Nanjing Sanhome Pharmaceutical Details
10.1.2 Nanjing Sanhome Pharmaceutical Major Business
10.1.3 Nanjing Sanhome Pharmaceutical Reritinib Mesylate Tablets Product and Services
10.1.4 Nanjing Sanhome Pharmaceutical Reritinib Mesylate Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Nanjing Sanhome Pharmaceutical Recent Developments/Updates
10.1.6 Nanjing Sanhome Pharmaceutical Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Reritinib Mesylate Tablets Industry Chain
11.2 Reritinib Mesylate Tablets Upstream Analysis
11.2.1 Reritinib Mesylate Tablets Core Raw Materials
11.2.2 Main Manufacturers of Reritinib Mesylate Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Reritinib Mesylate Tablets Production Mode
11.6 Reritinib Mesylate Tablets Procurement Model
11.7 Reritinib Mesylate Tablets Industry Sales Model and Sales Channels
11.7.1 Reritinib Mesylate Tablets Sales Model
11.7.2 Reritinib Mesylate Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Reritinib Mesylate Tablets Introduction
1.2 World Reritinib Mesylate Tablets Supply & Forecast
1.2.1 World Reritinib Mesylate Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Reritinib Mesylate Tablets Production (2021-2032)
1.2.3 World Reritinib Mesylate Tablets Pricing Trends (2021-2032)
1.3 World Reritinib Mesylate Tablets Production by Region (Based on Production Site)
1.3.1 World Reritinib Mesylate Tablets Production Value by Region (2021-2032)
1.3.2 World Reritinib Mesylate Tablets Production by Region (2021-2032)
1.3.3 World Reritinib Mesylate Tablets Average Price by Region (2021-2032)
1.3.4 North America Reritinib Mesylate Tablets Production (2021-2032)
1.3.5 Europe Reritinib Mesylate Tablets Production (2021-2032)
1.3.6 China Reritinib Mesylate Tablets Production (2021-2032)
1.3.7 Japan Reritinib Mesylate Tablets Production (2021-2032)
1.3.8 India Reritinib Mesylate Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Reritinib Mesylate Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Reritinib Mesylate Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Reritinib Mesylate Tablets Demand (2021-2032)
2.2 World Reritinib Mesylate Tablets Consumption by Region
2.2.1 World Reritinib Mesylate Tablets Consumption by Region (2021-2026)
2.2.2 World Reritinib Mesylate Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Reritinib Mesylate Tablets Consumption (2021-2032)
2.4 China Reritinib Mesylate Tablets Consumption (2021-2032)
2.5 Europe Reritinib Mesylate Tablets Consumption (2021-2032)
2.6 Japan Reritinib Mesylate Tablets Consumption (2021-2032)
2.7 South Korea Reritinib Mesylate Tablets Consumption (2021-2032)
2.8 ASEAN Reritinib Mesylate Tablets Consumption (2021-2032)
2.9 India Reritinib Mesylate Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Reritinib Mesylate Tablets Production Value by Manufacturer (2021-2026)
3.2 World Reritinib Mesylate Tablets Production by Manufacturer (2021-2026)
3.3 World Reritinib Mesylate Tablets Average Price by Manufacturer (2021-2026)
3.4 Reritinib Mesylate Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Reritinib Mesylate Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Reritinib Mesylate Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Reritinib Mesylate Tablets in 2025
3.6 Reritinib Mesylate Tablets Market: Overall Company Footprint Analysis
3.6.1 Reritinib Mesylate Tablets Market: Region Footprint
3.6.2 Reritinib Mesylate Tablets Market: Company Product Type Footprint
3.6.3 Reritinib Mesylate Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Reritinib Mesylate Tablets Production Value Comparison
4.1.1 United States VS China: Reritinib Mesylate Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Reritinib Mesylate Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Reritinib Mesylate Tablets Production Comparison
4.2.1 United States VS China: Reritinib Mesylate Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Reritinib Mesylate Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Reritinib Mesylate Tablets Consumption Comparison
4.3.1 United States VS China: Reritinib Mesylate Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Reritinib Mesylate Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Reritinib Mesylate Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
4.5 China Based Reritinib Mesylate Tablets Manufacturers and Market Share
4.5.1 China Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
4.6 Rest of World Based Reritinib Mesylate Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Reritinib Mesylate Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Reritinib Mesylate Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Reritinib Mesylate Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Reritinib Mesylate Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg / tablet
5.2.2 80mg / tablet
5.3 Market Segment by Type
5.3.1 World Reritinib Mesylate Tablets Production by Type (2021-2032)
5.3.2 World Reritinib Mesylate Tablets Production Value by Type (2021-2032)
5.3.3 World Reritinib Mesylate Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Reritinib Mesylate Tablets Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Bottle
6.2.2 Box
6.3 Market Segment by Packaging
6.3.1 World Reritinib Mesylate Tablets Production by Packaging (2021-2032)
6.3.2 World Reritinib Mesylate Tablets Production Value by Packaging (2021-2032)
6.3.3 World Reritinib Mesylate Tablets Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNEL
7.1 World Reritinib Mesylate Tablets Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channel
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channel
7.3.1 World Reritinib Mesylate Tablets Production by Sales Channel (2021-2032)
7.3.2 World Reritinib Mesylate Tablets Production Value by Sales Channel (2021-2032)
7.3.3 World Reritinib Mesylate Tablets Average Price by Sales Channel (2021-2032)
8 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
8.1 World Reritinib Mesylate Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Production Technology
8.2.1 Innovator
8.2.2 Generic
8.3 Market Segment by Production Technology
8.3.1 World Reritinib Mesylate Tablets Production by Production Technology (2021-2032)
8.3.2 World Reritinib Mesylate Tablets Production Value by Production Technology (2021-2032)
8.3.3 World Reritinib Mesylate Tablets Average Price by Production Technology (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Reritinib Mesylate Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 EGFR-Sensitive Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
9.2.2 Non-Small Cell Lung Cancer With T790M Resistance Mutation After Progression on EGFR-TKI Therapy
9.2.3 Second-Line Targeted Therapy for Advanced Non-Small Cell Lung Cancer
9.2.4 Others
9.3 Market Segment by Application
9.3.1 World Reritinib Mesylate Tablets Production by Application (2021-2032)
9.3.2 World Reritinib Mesylate Tablets Production Value by Application (2021-2032)
9.3.3 World Reritinib Mesylate Tablets Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Nanjing Sanhome Pharmaceutical
10.1.1 Nanjing Sanhome Pharmaceutical Details
10.1.2 Nanjing Sanhome Pharmaceutical Major Business
10.1.3 Nanjing Sanhome Pharmaceutical Reritinib Mesylate Tablets Product and Services
10.1.4 Nanjing Sanhome Pharmaceutical Reritinib Mesylate Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Nanjing Sanhome Pharmaceutical Recent Developments/Updates
10.1.6 Nanjing Sanhome Pharmaceutical Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Reritinib Mesylate Tablets Industry Chain
11.2 Reritinib Mesylate Tablets Upstream Analysis
11.2.1 Reritinib Mesylate Tablets Core Raw Materials
11.2.2 Main Manufacturers of Reritinib Mesylate Tablets Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Reritinib Mesylate Tablets Production Mode
11.6 Reritinib Mesylate Tablets Procurement Model
11.7 Reritinib Mesylate Tablets Industry Sales Model and Sales Channels
11.7.1 Reritinib Mesylate Tablets Sales Model
11.7.2 Reritinib Mesylate Tablets Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Reritinib MesylateTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Reritinib MesylateTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Reritinib MesylateTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Reritinib MesylateTablets Production Value Market Share by Region (2021-2026)
Table 5. World Reritinib MesylateTablets Production Value Market Share by Region (2027-2032)
Table 6. World Reritinib MesylateTablets Production by Region (2021-2026) & (Units)
Table 7. World Reritinib MesylateTablets Production by Region (2027-2032) & (Units)
Table 8. World Reritinib MesylateTablets Production Market Share by Region (2021-2026)
Table 9. World Reritinib MesylateTablets Production Market Share by Region (2027-2032)
Table 10. World Reritinib MesylateTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Reritinib MesylateTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Reritinib MesylateTablets Major Market Trends
Table 13. World Reritinib MesylateTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Reritinib MesylateTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Reritinib MesylateTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Reritinib MesylateTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Reritinib MesylateTablets Producers in 2025
Table 18. World Reritinib MesylateTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Reritinib MesylateTablets Producers in 2025
Table 20. World Reritinib MesylateTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Reritinib MesylateTablets Company Evaluation Quadrant
Table 22. World Reritinib MesylateTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Reritinib MesylateTablets Production Site of Key Manufacturer
Table 24. Reritinib MesylateTablets Market: Company Product Type Footprint
Table 25. Reritinib MesylateTablets Market: Company Product Application Footprint
Table 26. Reritinib MesylateTablets Competitive Factors
Table 27. Reritinib MesylateTablets New Entrant and Capacity Expansion Plans
Table 28. Reritinib MesylateTablets Mergers & Acquisitions Activity
Table 29. United States VS China Reritinib MesylateTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Reritinib MesylateTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Reritinib MesylateTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Reritinib MesylateTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 37. China Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Reritinib MesylateTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Reritinib MesylateTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 47. World Reritinib MesylateTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Reritinib MesylateTablets Production by Type (2021-2026) & (Units)
Table 49. World Reritinib MesylateTablets Production by Type (2027-2032) & (Units)
Table 50. World Reritinib MesylateTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Reritinib MesylateTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Reritinib MesylateTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Reritinib MesylateTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Reritinib MesylateTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World Reritinib MesylateTablets Production by Packaging (2021-2026) & (Units)
Table 56. World Reritinib MesylateTablets Production by Packaging (2027-2032) & (Units)
Table 57. World Reritinib MesylateTablets Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World Reritinib MesylateTablets Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World Reritinib MesylateTablets Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World Reritinib MesylateTablets Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World Reritinib MesylateTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 62. World Reritinib MesylateTablets Production by Sales Channel (2021-2026) & (Units)
Table 63. World Reritinib MesylateTablets Production by Sales Channel (2027-2032) & (Units)
Table 64. World Reritinib MesylateTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 65. World Reritinib MesylateTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 66. World Reritinib MesylateTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 67. World Reritinib MesylateTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 68. World Reritinib MesylateTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Reritinib MesylateTablets Production by Production Technology (2021-2026) & (Units)
Table 70. World Reritinib MesylateTablets Production by Production Technology (2027-2032) & (Units)
Table 71. World Reritinib MesylateTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 72. World Reritinib MesylateTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 73. World Reritinib MesylateTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 74. World Reritinib MesylateTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 75. World Reritinib MesylateTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Reritinib MesylateTablets Production by Application (2021-2026) & (Units)
Table 77. World Reritinib MesylateTablets Production by Application (2027-2032) & (Units)
Table 78. World Reritinib MesylateTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World Reritinib MesylateTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World Reritinib MesylateTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Reritinib MesylateTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Nanjing Sanhome Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 83. Nanjing Sanhome Pharmaceutical Major Business
Table 84. Nanjing Sanhome Pharmaceutical Reritinib MesylateTablets Product and Services
Table 85. Nanjing Sanhome Pharmaceutical Reritinib MesylateTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Nanjing Sanhome Pharmaceutical Recent Developments/Updates
Table 87. Nanjing Sanhome Pharmaceutical Competitive Strengths & Weaknesses
Table 88. Global Key Players of Reritinib MesylateTablets Upstream (Raw Materials)
Table 89. Global Reritinib MesylateTablets Typical Customers
Table 90. Reritinib MesylateTablets Typical Distributors
Table 1. World Reritinib MesylateTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Reritinib MesylateTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Reritinib MesylateTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Reritinib MesylateTablets Production Value Market Share by Region (2021-2026)
Table 5. World Reritinib MesylateTablets Production Value Market Share by Region (2027-2032)
Table 6. World Reritinib MesylateTablets Production by Region (2021-2026) & (Units)
Table 7. World Reritinib MesylateTablets Production by Region (2027-2032) & (Units)
Table 8. World Reritinib MesylateTablets Production Market Share by Region (2021-2026)
Table 9. World Reritinib MesylateTablets Production Market Share by Region (2027-2032)
Table 10. World Reritinib MesylateTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Reritinib MesylateTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Reritinib MesylateTablets Major Market Trends
Table 13. World Reritinib MesylateTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Reritinib MesylateTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Reritinib MesylateTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Reritinib MesylateTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Reritinib MesylateTablets Producers in 2025
Table 18. World Reritinib MesylateTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Reritinib MesylateTablets Producers in 2025
Table 20. World Reritinib MesylateTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Reritinib MesylateTablets Company Evaluation Quadrant
Table 22. World Reritinib MesylateTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Reritinib MesylateTablets Production Site of Key Manufacturer
Table 24. Reritinib MesylateTablets Market: Company Product Type Footprint
Table 25. Reritinib MesylateTablets Market: Company Product Application Footprint
Table 26. Reritinib MesylateTablets Competitive Factors
Table 27. Reritinib MesylateTablets New Entrant and Capacity Expansion Plans
Table 28. Reritinib MesylateTablets Mergers & Acquisitions Activity
Table 29. United States VS China Reritinib MesylateTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Reritinib MesylateTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Reritinib MesylateTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Reritinib MesylateTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 37. China Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Reritinib MesylateTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Reritinib MesylateTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Reritinib MesylateTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Reritinib MesylateTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Reritinib MesylateTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Reritinib MesylateTablets Production Market Share (2021-2026)
Table 47. World Reritinib MesylateTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Reritinib MesylateTablets Production by Type (2021-2026) & (Units)
Table 49. World Reritinib MesylateTablets Production by Type (2027-2032) & (Units)
Table 50. World Reritinib MesylateTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Reritinib MesylateTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Reritinib MesylateTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Reritinib MesylateTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Reritinib MesylateTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World Reritinib MesylateTablets Production by Packaging (2021-2026) & (Units)
Table 56. World Reritinib MesylateTablets Production by Packaging (2027-2032) & (Units)
Table 57. World Reritinib MesylateTablets Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World Reritinib MesylateTablets Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World Reritinib MesylateTablets Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World Reritinib MesylateTablets Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World Reritinib MesylateTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 62. World Reritinib MesylateTablets Production by Sales Channel (2021-2026) & (Units)
Table 63. World Reritinib MesylateTablets Production by Sales Channel (2027-2032) & (Units)
Table 64. World Reritinib MesylateTablets Production Value by Sales Channel (2021-2026) & (USD Million)
Table 65. World Reritinib MesylateTablets Production Value by Sales Channel (2027-2032) & (USD Million)
Table 66. World Reritinib MesylateTablets Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 67. World Reritinib MesylateTablets Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 68. World Reritinib MesylateTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 69. World Reritinib MesylateTablets Production by Production Technology (2021-2026) & (Units)
Table 70. World Reritinib MesylateTablets Production by Production Technology (2027-2032) & (Units)
Table 71. World Reritinib MesylateTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 72. World Reritinib MesylateTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 73. World Reritinib MesylateTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 74. World Reritinib MesylateTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 75. World Reritinib MesylateTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Reritinib MesylateTablets Production by Application (2021-2026) & (Units)
Table 77. World Reritinib MesylateTablets Production by Application (2027-2032) & (Units)
Table 78. World Reritinib MesylateTablets Production Value by Application (2021-2026) & (USD Million)
Table 79. World Reritinib MesylateTablets Production Value by Application (2027-2032) & (USD Million)
Table 80. World Reritinib MesylateTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Reritinib MesylateTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Nanjing Sanhome Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 83. Nanjing Sanhome Pharmaceutical Major Business
Table 84. Nanjing Sanhome Pharmaceutical Reritinib MesylateTablets Product and Services
Table 85. Nanjing Sanhome Pharmaceutical Reritinib MesylateTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Nanjing Sanhome Pharmaceutical Recent Developments/Updates
Table 87. Nanjing Sanhome Pharmaceutical Competitive Strengths & Weaknesses
Table 88. Global Key Players of Reritinib MesylateTablets Upstream (Raw Materials)
Table 89. Global Reritinib MesylateTablets Typical Customers
Table 90. Reritinib MesylateTablets Typical Distributors
LIST OF FIGURES
Figure 1. Reritinib MesylateTablets Picture
Figure 2. World Reritinib MesylateTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Reritinib MesylateTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 5. World Reritinib MesylateTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Reritinib MesylateTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Reritinib MesylateTablets Production Market Share by Region (2021-2032)
Figure 8. North America Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 9. Europe Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 10. China Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 11. Japan Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 12. India Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 13. Reritinib MesylateTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 16. World Reritinib MesylateTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 18. China Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 23. India Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Reritinib MesylateTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Reritinib MesylateTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Reritinib MesylateTablets Markets in 2025
Figure 27. United States VS China: Reritinib MesylateTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Reritinib MesylateTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Reritinib MesylateTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 31. China Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 33. World Reritinib MesylateTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Reritinib MesylateTablets Production Value Market Share by Type in 2025
Figure 35. 100mg / tablet
Figure 36. 80mg / tablet
Figure 37. World Reritinib MesylateTablets Production Market Share by Type (2021-2032)
Figure 38. World Reritinib MesylateTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Reritinib MesylateTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Reritinib MesylateTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 41. World Reritinib MesylateTablets Production Value Market Share by Packaging in 2025
Figure 42. Bottle
Figure 43. Box
Figure 44. World Reritinib MesylateTablets Production Market Share by Packaging (2021-2032)
Figure 45. World Reritinib MesylateTablets Production Value Market Share by Packaging (2021-2032)
Figure 46. World Reritinib MesylateTablets Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 47. World Reritinib MesylateTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 48. World Reritinib MesylateTablets Production Value Market Share by Sales Channel in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Reritinib MesylateTablets Production Market Share by Sales Channel (2021-2032)
Figure 53. World Reritinib MesylateTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 54. World Reritinib MesylateTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 55. World Reritinib MesylateTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Reritinib MesylateTablets Production Value Market Share by Production Technology in 2025
Figure 57. Innovator
Figure 58. Generic
Figure 59. World Reritinib MesylateTablets Production Market Share by Production Technology (2021-2032)
Figure 60. World Reritinib MesylateTablets Production Value Market Share by Production Technology (2021-2032)
Figure 61. World Reritinib MesylateTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 62. World Reritinib MesylateTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Reritinib MesylateTablets Production Value Market Share by Application in 2025
Figure 64. EGFR-Sensitive Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Figure 65. Non-Small Cell Lung Cancer With T790M Resistance Mutation After Progression on EGFR-TKI Therapy
Figure 66. Second-Line Targeted Therapy for Advanced Non-Small Cell Lung Cancer
Figure 67. Others
Figure 68. World Reritinib MesylateTablets Production Market Share by Application (2021-2032)
Figure 69. World Reritinib MesylateTablets Production Value Market Share by Application (2021-2032)
Figure 70. World Reritinib MesylateTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Reritinib MesylateTablets Industry Chain
Figure 72. Reritinib MesylateTablets Procurement Model
Figure 73. Reritinib MesylateTablets Sales Model
Figure 74. Reritinib MesylateTablets Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Reritinib MesylateTablets Picture
Figure 2. World Reritinib MesylateTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Reritinib MesylateTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 5. World Reritinib MesylateTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Reritinib MesylateTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Reritinib MesylateTablets Production Market Share by Region (2021-2032)
Figure 8. North America Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 9. Europe Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 10. China Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 11. Japan Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 12. India Reritinib MesylateTablets Production (2021-2032) & (Units)
Figure 13. Reritinib MesylateTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 16. World Reritinib MesylateTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 18. China Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 23. India Reritinib MesylateTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Reritinib MesylateTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Reritinib MesylateTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Reritinib MesylateTablets Markets in 2025
Figure 27. United States VS China: Reritinib MesylateTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Reritinib MesylateTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Reritinib MesylateTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 31. China Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Reritinib MesylateTablets Production Market Share 2025
Figure 33. World Reritinib MesylateTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Reritinib MesylateTablets Production Value Market Share by Type in 2025
Figure 35. 100mg / tablet
Figure 36. 80mg / tablet
Figure 37. World Reritinib MesylateTablets Production Market Share by Type (2021-2032)
Figure 38. World Reritinib MesylateTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Reritinib MesylateTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Reritinib MesylateTablets Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 41. World Reritinib MesylateTablets Production Value Market Share by Packaging in 2025
Figure 42. Bottle
Figure 43. Box
Figure 44. World Reritinib MesylateTablets Production Market Share by Packaging (2021-2032)
Figure 45. World Reritinib MesylateTablets Production Value Market Share by Packaging (2021-2032)
Figure 46. World Reritinib MesylateTablets Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 47. World Reritinib MesylateTablets Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 48. World Reritinib MesylateTablets Production Value Market Share by Sales Channel in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Reritinib MesylateTablets Production Market Share by Sales Channel (2021-2032)
Figure 53. World Reritinib MesylateTablets Production Value Market Share by Sales Channel (2021-2032)
Figure 54. World Reritinib MesylateTablets Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 55. World Reritinib MesylateTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 56. World Reritinib MesylateTablets Production Value Market Share by Production Technology in 2025
Figure 57. Innovator
Figure 58. Generic
Figure 59. World Reritinib MesylateTablets Production Market Share by Production Technology (2021-2032)
Figure 60. World Reritinib MesylateTablets Production Value Market Share by Production Technology (2021-2032)
Figure 61. World Reritinib MesylateTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 62. World Reritinib MesylateTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Reritinib MesylateTablets Production Value Market Share by Application in 2025
Figure 64. EGFR-Sensitive Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Figure 65. Non-Small Cell Lung Cancer With T790M Resistance Mutation After Progression on EGFR-TKI Therapy
Figure 66. Second-Line Targeted Therapy for Advanced Non-Small Cell Lung Cancer
Figure 67. Others
Figure 68. World Reritinib MesylateTablets Production Market Share by Application (2021-2032)
Figure 69. World Reritinib MesylateTablets Production Value Market Share by Application (2021-2032)
Figure 70. World Reritinib MesylateTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 71. Reritinib MesylateTablets Industry Chain
Figure 72. Reritinib MesylateTablets Procurement Model
Figure 73. Reritinib MesylateTablets Sales Model
Figure 74. Reritinib MesylateTablets Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
